DE2403065A1 - Verfahren zur herstellung therapeutischer blutfraktionen - Google Patents

Verfahren zur herstellung therapeutischer blutfraktionen

Info

Publication number
DE2403065A1
DE2403065A1 DE2403065A DE2403065A DE2403065A1 DE 2403065 A1 DE2403065 A1 DE 2403065A1 DE 2403065 A DE2403065 A DE 2403065A DE 2403065 A DE2403065 A DE 2403065A DE 2403065 A1 DE2403065 A1 DE 2403065A1
Authority
DE
Germany
Prior art keywords
concentration
supernatant liquid
block copolymer
copolymer
precipitate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2403065A
Other languages
German (de)
English (en)
Inventor
Luis A Garcia
Guido A Ordonez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of DE2403065A1 publication Critical patent/DE2403065A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE2403065A 1973-01-30 1974-01-23 Verfahren zur herstellung therapeutischer blutfraktionen Withdrawn DE2403065A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32789373A 1973-01-30 1973-01-30

Publications (1)

Publication Number Publication Date
DE2403065A1 true DE2403065A1 (de) 1974-08-01

Family

ID=23278536

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2403065A Withdrawn DE2403065A1 (de) 1973-01-30 1974-01-23 Verfahren zur herstellung therapeutischer blutfraktionen

Country Status (10)

Country Link
JP (1) JPS49102820A (es)
AU (1) AU6495474A (es)
BE (1) BE810217A (es)
CA (1) CA984748A (es)
DE (1) DE2403065A1 (es)
ES (1) ES422767A1 (es)
FR (1) FR2215241B1 (es)
GB (1) GB1449333A (es)
IL (1) IL44023A (es)
ZA (1) ZA74350B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944391A (en) * 1974-12-27 1976-03-16 Preventive Systems, Inc. In vitro process for detecting endotoxin in a biological fluid
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
JPS5843369B2 (ja) * 1977-09-10 1983-09-27 森六株式会社 血清蛋白質の分画方法
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation

Also Published As

Publication number Publication date
BE810217A (fr) 1974-05-16
ZA74350B (en) 1974-11-27
IL44023A0 (en) 1974-05-16
IL44023A (en) 1977-05-31
CA984748A (en) 1976-03-02
FR2215241A1 (es) 1974-08-23
FR2215241B1 (es) 1977-03-11
ES422767A1 (es) 1976-06-01
AU6495474A (en) 1975-07-31
GB1449333A (en) 1976-09-15
JPS49102820A (es) 1974-09-28

Similar Documents

Publication Publication Date Title
US3956259A (en) Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
DE2029455C3 (de) Verfahren zur Herstellung eines neuen Prothrombinkomplexes
DE2231676A1 (de) Verfahren zur fraktionierung von blutserum und plasmaprodukten
DE2404041A1 (de) Blut-fraktionierungsverfahren
DE2751717C2 (es)
DE2734821C3 (de) Blutgerinnungsfördernde Präparation und Verfahren zu ihrer Herstellung
EP0270025B1 (de) Verfahren zur Herstellung eines intravenös anwendbaren und in flüssiger Form stabilen Immunglobulins
DE2459291C3 (de) Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3984539A (en) Bovine immunoglobulin isolation process
Cohn Chemical, physiological, and immunological properties and clinical uses of blood derivatives
DE2324717A1 (de) Verfahren zur verbesserung der ausbeute an antihaemophilem faktor a
DE3112539A1 (de) Verfahren zur auftrennung von waessrigen proteingemischen
EP0311950A2 (de) Verfahren zur Herstellung einer sterilen Plasmaproteinlösung, die Fibrinogen und den Gerinnungsfaktor XIII enthält
DE2854381A1 (de) Verfahren zur gewinnung des antihaemophilen faktors viii aus blut, blutplasma oder blutplasma-fraktionen
LU83577A1 (de) Verfahren zur herstellung eines faktor viii(ahf)-hochkonzentrates
DE2127159A1 (de) Verfahren zur Fraktionierung von Plasmaproteinen
DE2403994A1 (de) Herstellung von antisera
US4025500A (en) Preparation of albumin by fractionation of blood plasma or serum
DE2403065A1 (de) Verfahren zur herstellung therapeutischer blutfraktionen
CH338273A (de) Verfahren zur Herstellung stabiler, hochgereinigter y-Globulinpräparate
DE2713817A1 (de) Verfahren zum gewinnen von immunglobulin
DE2357800A1 (de) Verfahren zur herstellung von gammaglobulin
EP0120835A2 (de) Verfahren zur Inaktivierung von Unverträglichkeitsreaktionen verursachenden Substanzen
DE2428982A1 (de) Verfahren zur herstellung einer blutfraktion
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination